ABCC3 genetic variants are associated with postoperative morphine-induced respiratory depression and morphine pharmacokinetics in children

被引:0
作者
V Chidambaran
R Venkatasubramanian
X Zhang
L J Martin
J Niu
T Mizuno
T Fukuda
J Meller
A A Vinks
S Sadhasivam
机构
[1] College of Medicine,Department of Anesthesia
[2] University of Cincinnati,Department of Pediatrics
[3] College of Medicine,Division of Clinical Pharmacology
[4] University of Cincinnati,Division of Human Genetics
[5] Cincinnati Children’s Hospital Medical Center,Division of Bioinformatics
[6] Cincinnati Children’s Hospital Medical Center,undefined
[7] Cincinnati Children’s Hospital Medical Center,undefined
来源
The Pharmacogenomics Journal | 2017年 / 17卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Respiratory depression (RD) is a serious side effect of morphine and detrimental to effective analgesia. We reported that variants of the ATP binding cassette gene ABCC3 (facilitates hepatic morphine metabolite efflux) affect morphine metabolite clearance. In this study of 316 children undergoing tonsillectomy, we found significant association between ABCC3 variants and RD leading to prolonged postoperative care unit stay (prolonged RD). Allele A at rs4148412 and allele G at rs729923 caused a 2.36 (95% CI=1.28–4.37, P=0.0061) and 3.7 (95% CI 1.47–9.09, P=0.0050) times increase in odds of prolonged RD, respectively. These clinical associations were supported by increased formation clearance of morphine glucuronides in children with rs4148412 AA and rs4973665 CC genotypes in this cohort, as well as an independent spine surgical cohort of 67 adolescents. This is the first study to report association of ABCC3 variants with opioid-related RD, and morphine metabolite formation (in two independent surgical cohorts).
引用
收藏
页码:162 / 169
页数:7
相关论文
共 50 条
[31]   Ethanol's Effects on Morphine-Induced Tolerance of Respiratory Depression [J].
Prommer, Eric .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2016, 51 (02) :302-303
[32]   Reversal of morphine-induced respiratory depression by doxapram in anesthetized rats [J].
Haji, Akira ;
Kimura, Satoko ;
Ohi, Yoshiaki .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2016, 780 :209-215
[33]   INTRALINGUAL NALOXONE REVERSAL OF MORPHINE-INDUCED RESPIRATORY DEPRESSION IN DOGS [J].
MAIO, RF ;
GRIENER, JC ;
CLARK, MR ;
GIFFORD, G ;
WIEGENSTEIN, JG .
ANNALS OF EMERGENCY MEDICINE, 1984, 13 (12) :1087-1091
[34]   Replication of TPMT and ABCC3 Genetic Variants Highly Associated With Cisplatin-Induced Hearing Loss in Children [J].
Pussegoda, K. ;
Ross, C. J. ;
Visscher, H. ;
Yazdanpanah, M. ;
Brooks, B. ;
Rassekh, S. R. ;
Zada, Y. F. ;
Dube, M-P ;
Carleton, B. C. ;
Hayden, M. R. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 94 (02) :243-251
[35]   PHARMACOKINETICS AND PHARMACODYNAMICS USED IN DOSAGE OF IV NALBUPHINE (N) FOR PREVENTION OF MORPHINE-INDUCED RESPIRATORY DEPRESSION (EPIDURAL) [J].
DUBE, LM ;
BEAUDOIN, N ;
BAXTER, A ;
SAMSON, B ;
DORAN, R ;
MCGILVERAY, IJ .
CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1987, 10 (04) :B57-B57
[36]   Effects of neuroactive substances on the morphine-induced respiratory depression; an in vitro study [J].
Takita, K ;
Herlenius, E ;
Yamamoto, Y ;
Lindahl, SGE .
BRAIN RESEARCH, 2000, 884 (1-2) :201-205
[37]   PHYSOSTIGMINE ANTAGONIZES MORPHINE-INDUCED RESPIRATORY DEPRESSION IN HUMAN-SUBJECTS [J].
SNIRMOR, I ;
WEINSTOCK, M ;
DAVIDSON, JT ;
BAHAR, M .
ANESTHESIOLOGY, 1983, 59 (01) :6-9
[38]   EFFECTS OF VERAPAMIL ON MORPHINE-INDUCED EUPHORIA, ANALGESIA AND RESPIRATORY DEPRESSION IN HUMANS [J].
VAUPEL, DB ;
LANGE, WR ;
LONDON, ED .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1993, 267 (03) :1386-1394
[39]   Morphine-induced respiratory depression is independent of β-arrestin2 signalling [J].
Kliewer, Andrea ;
Gillis, Alexander ;
Hill, Rob ;
Schmidel, Frank ;
Bailey, Chris ;
Kelly, Eamonn ;
Henderson, Graeme ;
Christie, Macdonald J. ;
Schulz, Stefan .
BRITISH JOURNAL OF PHARMACOLOGY, 2020, 177 (13) :2923-2931
[40]   ROLE OF MONO-AMINERGIC SYSTEMS IN MORPHINE-INDUCED RESPIRATORY DEPRESSION [J].
MELDRUM, MJ ;
ISOM, GE .
NEUROPHARMACOLOGY, 1981, 20 (02) :169-175